Feng Zhao

A Biparatopic Antibody–Drug Conjugate to Treat MET-Expressing Cancers, Including Those that Are Unresponsive to MET Pathway Blockade

Jason T Giurleo, M. Retter, G. Thurston, 2021, Molecular Cancer Therapeutics.

Antibody drug conjugates of cleavable amino-benzoyl-maytansinoids.

N. Papadopoulos, G. Thurston, Jing Shan, 2020, Bioorganic & medicinal chemistry.

Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids.

Jason T Giurleo, N. Papadopoulos, G. Thurston, 2018, Bioorganic & medicinal chemistry.

Development of Novel Glucocorticoids for Use in Antibody-Drug Conjugates for the Treatment of Inflammatory Diseases.

Jing Shan, W. Olson, Z. Hovhannisyan, 2021, Journal of medicinal chemistry.

Discovery of small molecule β-catenin suppressors that enhance immunotherapy.

Jingyu Wang, Yingpeng Li, Feng Zhao, 2023, Bioorganic chemistry.

Targeted drug delivery systems for elemene in cancer therapy: The story thus far.

Bing-tao Zhai, Huan Tian, Feng Zhao, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.